BioCentury
ARTICLE | Clinical News

Peramivir regulatory update

November 2, 2009 8:00 AM UTC

FDA granted an emergency use authorization (EUA) for IV peramivir from BioCryst to treat swine influenza A (H1N1). The neuraminidase inhibitor is authorized for hospitalized adult and pediatric patie...